The association of LOX-1 and oxLDL with diseases, such as endothelial dysfunction, atherosclerosis, acute myocardial infarction, stroke, diabetes, hypertension, metabolic syndrome and obesity, has been extensively studied [3], [5], [24]. Here, OLR1 is linked to metabolic syndrome.